Clinical Social Workers in Pequannock, NJ Accepting Medicare

5 Clinical Social Workers found. Showing 1 - 5

Christina Eromenok, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 180 Newark Pompton Tpke, Pequannock, NJ 07440 Phone: 973-800-5494

Mrs. Gloria Wyka, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7 Industrial Rd Ste 206, Pequannock, NJ 07440 Phone: 201-709-6548

Mr. Michael Louro, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24 Reynolds Rd, Pequannock, NJ 07440 Phone: 973-634-0887

Gertrude Monaco, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 7 Industrial Rd, Pequannock, NJ 07440 Phone: 973-686-2266

Natalie Joan Vance, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 7 Industrial Rd, Pequannock, NJ 07440 Phone: 973-839-2520

News Archive

Study reveals molecular steps for pneumonia therapy

A structural molecule and the cellular pump that regulates its levels influence the severity of pneumonia and could provide new ways of treating the lung infection, which is a leading cause of hospitalization and death, according to scientists at the University of Pittsburgh and the University of Iowa. Their findings are available online in Nature Medicine.

Department of Veterans Affairs cancels contract with UTSWMC for Gulf War research

Citing persistent noncompliance and numerous performance deficiencies, the Department of Veterans Affairs (VA) will not exercise the third year of a five-year, $75 million contract with the University of Texas Southwestern Medical Center (UTSWMC) to perform research into Gulf War Veterans' Illnesses (GWVI).

Research: Less than 10% of Medicare beneficiaries with heart failure get cardiac rehabilitation

Cardiac rehabilitation enrollment rose among adults with heart failure with reduced ejection fraction after Medicare started covering it in 2014, yet overall enrollment among Medicare beneficiaries remains very low – less than 10% of those eligible according to preliminary research to be presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2021.

FDA approves Cumberland's Acetadote Injection

Cumberland Pharmaceuticals today announced that it has received approval from the U.S. Food and Drug Administration for a new formulation of Acetadote Injection, the Company's product used to treat acetaminophen poisoning.

Research progress with promising Alzheimer's drug Xanamem

Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.

Read more Medical News

› Verified 7 days ago